acetylcysteine has been researched along with deferoxamine in 120 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.83) | 18.7374 |
1990's | 26 (21.67) | 18.2507 |
2000's | 48 (40.00) | 29.6817 |
2010's | 39 (32.50) | 24.3611 |
2020's | 6 (5.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Asano, K; Dodo, K; Imamura, R; Kuboki, E; Magarisawa, M; Nakao, S; Shimizu, T; Sodeoka, M; Suda, T; Takahashi, M; Tanaka, M; Terayama, N; Tokuhiro, T; Yotsumoto, S | 1 |
D'Acunto, CW; Gonzalez, G; Hodoň, J; Kaňovský, P; Kazakova, A; Strnad, M; Urban, M | 1 |
Davies, MJ; Newman, ES; Rice-Evans, CA; Turner, JJ | 1 |
Farber, JL; Hoek, JB; Starke, PE | 1 |
Blöhmer, A; Hänel, H; Heidemann, HT; Inselmann, G; Kottny, W; Nellessen, U | 1 |
Collis, CS; Davies, MJ; Rice-Evans, C | 1 |
Chambers, TJ; Fuller, K; Hall, TJ; Jeker, H; Schaeublin, M | 1 |
Klee, S; Nürnberger, MC; Ungemach, FR | 1 |
Proudfoot, AT | 1 |
Faux, SP; Howden, PJ | 1 |
Farinelli, SE; Greene, LA; Park, DS; Stefanis, L; Yan, CY | 1 |
Baraban, JM; Lee, PJ; Ratan, RR | 1 |
Bowden, CA; Krenzelok, EP | 1 |
Bowie, A; O'Neill, LA | 1 |
Galle, J; Galle, PR; Grambihler, A; Hack, V; Hug, H; Krammer, PH; Strand, S; Stremmel, W | 1 |
Higuchi, Y; Matsukawa, S | 1 |
Hansen, TW; Knisely, AS; Kocoshis, SA; Reyes, J; Rosh, J; Sigurdsson, L | 1 |
Czyzyk-Krzeska, MF; Kroll, SL | 1 |
Cheng, CC; Chiu, JJ; Hsieh, HJ; Wang, DL; Wu, ST; Wung, BS | 1 |
Boussa, N; Dutertre-Catella, H; Ernouf, D; Legras, A | 1 |
Fernandez, PA; Martinou, I; Martinou, JC; Missotten, M; Sadoul, R | 1 |
Devlin, RB; Quay, JL; Reed, W; Samet, J | 1 |
Danaee, H; Goldsmith, CA; Imrich, A; Kobzik, L; Ning, YY | 1 |
Fukuchi, K; Gomi, K; Nakamaki, T; Tomoyasu, S; Tsuruoka, N | 1 |
Bucci, TJ; Hinson, JA; Kusewitt, DF; Pumford, NR; Schnellmann, JG | 1 |
Fukuchi, K; Gomi, K; Maruyama, H; Takagi, Y | 1 |
Chen, CC; Chen, CL; Chi, CW; Liu, TY | 1 |
Hashimoto, M; Hsu, LJ; Masliah, E; Takeda, A; Takenouchi, T | 1 |
Harris, DC; Rangan, GK; Tay, YC; Wang, Y | 1 |
Defraigne, JO; Detry, O; Franssen, C; Limet, R; Meurisse, M; Pincemail, J | 1 |
Alvarez, AM; Andrés, D; Cascales, M; Díez-Fernández, C; Zaragoza, A | 2 |
Auer, M; Leib, SL; Leppert, D; Pfister, LA; Täuber, MG | 1 |
Diamond, E; Drigues, N; Klein, I; Lischinsky, S; Nagler, R; Reznick, AZ | 1 |
Baker, RD; Baker, SS; Gupta, A; Li, L; Rao, RK | 1 |
Lai, CC; Ryter, SW; Si, M; Su, CY | 1 |
Bauer, I; Bauer, M; Pannen, BH; Paxian, M; Rensing, H; Rickauer, A; Schmeck, J; Schönhofen, S | 1 |
Delogu, MR; Desole, MS; Esposito, G; Miele, E; Miele, M; Migheli, R; Rocchitta, G; Serra, PA | 1 |
Castranova, V; Costa, M; Huang, C; Ju, G; Leonard, SS; Li, J; Shi, X; Vallyathan, V; Zhang, Z | 1 |
Oliveira, DB; Turner, DR; Wu, Z | 1 |
Angelos, MG; Clanton, TL; Klawitter, PF; Murray, HN | 1 |
Backlund, PS; Bourdon, E; Drake, SK; Levine, RL; Rouault, TA; Wehr, NB; Yergey, AL | 1 |
Abdel-Naim, AB; Mohamadin, AM | 1 |
Caltagirone, A; Chahine, D; Fillebeen, C; Pantopoulos, K; Segal, P | 1 |
Balaspiri, L; Bogdanovic, N; Karelson, E; Land, T; Langel, U; Mahlapuu, R; Saar, K; Soomets, U; Viht, K; Zilmer, M | 1 |
Hatakeyama, M; Imaizumi, T; Kimura, D; Kumagai, M; Satoh, K; Tamo, W; Yamashita, K; Yoshida, H | 1 |
Andrades, ME; Dal-Pizzol, F; Menna-Barreto, S; Moreira, JC; Reinke, A; Ritter, C | 1 |
Crouser, ED | 1 |
Becker, HH; Dopp, E; Lohani, M; Poser, I; Rahman, Q; Schiffmann, D; Weiss, DG; Yadav, S | 1 |
Crommelin, DJ; Danhof, M; de Boer, AG; Visser, CC; Voorwinden, LH | 1 |
Andrades, M; Dal-Pizzol, F; Martins, MR; Menna-Barreto, S; Moreira, JC; Quevedo, J; Reinke, A; Ritter, C; Rocha, J | 1 |
Agani, FH; Gong, Y | 1 |
Le, W; Pan, T; Qu, S; Wang, X; Xie, W; Zhang, X | 1 |
Bockmühl, U; Fuchs, J; Gross, J; Jahnke, V; Kietzmann, T; Machulik, A | 1 |
Chakrabarti, SK; Lemieux, N; M'Bemba-Meka, P | 2 |
Dal-Pizzol, F; F Moreira, JC; Luiz Streck, E; Pinho, RA; Silva, LA; Silveira, PC | 1 |
Andrades, M; da Cunha, AA; Dal-Pizzol, F; Echer, IC; Lucchiari, N; Menna-Barreto, S; Moreira, JC; Reinke, A; Ritter, C; Rocha, J; Streck, EL | 1 |
Cross, CE; Halliwell, B; van Asbeck, BS | 1 |
Ameri, K; Culmsee, C; Davis, RJ; Denko, N; Hai, T; Hammond, EM; Harris, AL; Katschinski, DM; Raida, M; Wagner, E; Wenger, RH | 1 |
Howarth, ES; Venkat-Raman, N; Venkata-Krishnan, RV | 1 |
Arrigo, AP; Currie, RW; Firdaus, WJ; Giuliano, P; Kretz-Remy, C; Wyttenbach, A | 1 |
de Groot, H; Klempt, S; Rauen, U | 1 |
Akatov, VS; Faskhutdinova, AA; Kudriavtsev, AA; Solov'ev, VV; Solov'eva, ME | 1 |
Bardini, KC; Benetton, CA; Cardoso, VH; Dal-Pizzol, F; Damiani, CR; Di Giunta, G; Pinho, RA; Stoffel, C; Streck, EL | 1 |
Andrades, M; Bernard, EA; Dal-Pizzol, F; de Souza, LF; Moreira, JC; Pens Gelain, D; Ritter, C | 1 |
Blomqvist, G; Dahl, A; Gudmundsson, A; Gustafsson, M; Lindbom, J; Ljungman, AG; Swietlicki, E | 1 |
Barichello, T; Constantino, L; Dal-Pizzol, F; Machado, RA; Martins, MR; Petronilho, F; Quevedo, J; Réus, GZ; Ritter, C; Valvassori, SS | 1 |
Dal Pizzol, F; Pinho, RA; Rocha, LG; Silva, LA; Silveira, PC; Soares, FS; Streck, EL; Teixeira, KC; Valença, SS | 1 |
Aguiar, AS; da Rocha, LG; Pinho, RA; Silveira, PC; Soares, FS; Tuon, T | 1 |
Amer, J; Fibach, E; Ghoti, H; Rachmilewitz, E; Winder, A | 1 |
Arai, T; Hirota, K; Kodaki, T; Makino, K; Miyoshi, T; Mori, H; Sasada, M; Sommani, P; Tsunemine, H; Yamashita, K | 1 |
Burigo, M; Constantino, L; Dal-Pizzol, F; Di-Pietro, PB; Dias, ML; Machado, RA; Scaini, G; Streck, EL | 1 |
Boeck, CR; Dal-Pizzol, F; Kapczinski, F; Oliveira, VB; Petronilho, FC; Quevedo, J; Réus, GZ; Steckert, AV; Valvassori, SS | 1 |
Faurschou, A; Gniadecki, R | 1 |
Constantino, L; Dal-Pizzol, F; de Souza, B; Fraga, CM; Martins, MR; Petronilho, F; Reinke, A; Ritter, C | 1 |
Aydin, A; Bulucu, F; Inal, V; Karadurmus, N; Kenar, L; Koc, B; Ocal, R; Oktenli, C; Sahin, M; Yaman, H; Yamanel, L | 1 |
Andrades, M; Dal-Pizzol, F; de Oliveira, MR; Fonseca Moreira, JC; Ritter, C; Streck, EL | 1 |
Cassol, OJ; Dal-Pizzol, F; Ferreira, GK; Gonçalves, CL; Petronilho, FC; Rezin, GT; Roesler, R; Scaini, G; Schwartsmann, G; Streck, EL | 1 |
Barbosa, PR; Cardoso, MR; Dal-Pizzol, F; Daufenbach, JF; Gonçalves, CL; Machado, RA; Rezin, GT; Roza, CA; Scaini, G; Schuck, PF; Streck, EL | 1 |
Carvalho-Silva, M; Daufenbach, JF; Ferreira, GK; Gonçalves, CL; Jeremias, GC; Jeremias, IC; Panatto, JP; Ramos, AC; Rezin, GT; Rochi, N; Scaini, G; Streck, EL | 1 |
Altunhan, H; Annagür, A; Örs, R; Yüksekkaya, HA | 1 |
Aidasani, D; Reid, DL; Skiles, GL; Subramanian, R; Tam, J | 1 |
Caruana, M; Giese, A; Hillmer, A; Högen, T; Levin, J; Vassallo, N | 1 |
Biff, D; Dal-Pizzol, F; Felisberto, F; Fraga, CM; Petronilho, F; Ritter, C; Tomasi, CD; Topanotti, MF; Vuolo, F | 1 |
Comim, CM; Dominguini, D; Ferreira, GC; Jeremias, IC; Mina, F; Morais, MO; Pescador, B; Quevedo, J; Scaini, G; Schuck, PF; Streck, EL; Teodorak, BP | 1 |
Barichello, T; Comim, CM; Dal-Pizzol, F; Generoso, JS; Michelon, CM; Mina, F; Otaran, P; Quevedo, J; Santos, AL; Savi, GD; Steckert, AV | 1 |
Abelaira, HM; Arent, CO; Dal-Pizzol, F; Mina, F; Quevedo, J; Réus, GZ; Ribeiro, KF; Steckert, AV | 1 |
Benoit-Vical, F; Berry, A; Gales, A; Huyghe, E; Njomnang Soh, P; Pipy, B; Witkowski, B | 1 |
Bogo, MR; Comim, CM; Ferreira, GC; Gelain, DP; Moreira, JC; Oliveira, GM; Pasquali, MA; Quevedo, J; Scaini, G; Schuck, PF; Streck, EL | 1 |
Boesch-Saadatmandi, C; Ciesla, M; Dulak, J; Jozkowicz, A; Kozakowska, M; Loboda, A; Rimbach, G; Stachurska, A; Wolffram, S | 1 |
Brodsky, SV; Hebert, LA; Nadasdy, G; Nadasdy, T; Ozcan, A; Qamri, Z; Rovin, BH; Satoskar, AA; Ware, K | 1 |
Chang, SW; Chung, JH; Kim, EC; Kim, YS; Lee, YM; Noh, K | 1 |
Evans, TW; Griffiths, MJ; Mumby, S; Quinlan, GJ; Ramakrishnan, L | 1 |
Ibrahim, MA; Isah, MB | 1 |
Gutierrez, E; Jansson, PJ; Richardson, DR | 1 |
Bollineli, RC; Marques, MJ; Minatel, E; Mizobuti, DS; Moraes, LH; Silveira, Ldos R | 1 |
Jiménez-Vélez, BD; Ortiz-Martínez, MG; Rodríguez-Cotto, RI | 1 |
Amboni, RT; Arent, CO; Bianchini, G; Dal-Pont, GC; Lopes-Borges, J; Quevedo, J; Resende, WR; Steckert, AV; Valvassori, SS | 1 |
Andrades, M; Biolo, A; Clausell, N; Cohen, C; Dal-Pizzol, F; Lopes, A; Martinelli, N; Olsen, V; Phaelante, A; Rohde, LE; Tobar, SA | 1 |
Abelaira, HM; Bruchchen, L; Carlessi, AS; Ceretta, LB; Dos Santos, MA; Florentino, D; Matias, BI; Petronilho, F; Quevedo, J; Réus, GZ; Titus, SE; Vieira, A; Zugno, AI | 1 |
Abelaira, HM; Arent, CO; Bernardini Dos Santos, MA; Bruchchen, L; Carvalho, AF; Dal-Pizzol, F; Ignácio, ZM; Maciel, AL; Matias, BI; Michels, M; Quevedo, J; Réus, GZ; Zugno, AI | 1 |
Arkadopoulos, NF; Dimas, C; Karmaniolou, II; Kondi-Pafiti, AI; Lolis, ED; Mylonas, AI; Orfanos, NF; Papalois, AE; Smyrniotis, VE; Stergiou, IP | 1 |
Chattipakorn, N; Chattipakorn, SC; Krintratun, W; Sripetchwandee, J; Wongjaikam, S | 1 |
Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Khamseekaew, J; Kumfu, S; Srichairatanakool, S; Sripetchwandee, J; Wongjaikam, S | 1 |
Arkadopoulos, N; Karmaniolou, I; Mani, A; Mylonas, A; Nomikos, T; Orfanos, N; Pafiti, A; Papalois, A; Smyrniotis, V; Staikou, C; Theodoraki, K | 1 |
Dal-Pizzol, F; Damasio, DC; Fraga, CM; Ritter, C; Tomasi, CD; Vuolo, F | 1 |
Carvalho-Silva, M; De Prá, SD; Ferreira, GC; Gomes, LM; Rebelo, J; Scaini, G; Schuck, PF; Streck, EL; Teixeira, LJ; Teodorak, BP; Zeni, N | 1 |
Adedoyin, O; Agarwal, A; Boddu, R; Bolisetty, S; George, JF; Lever, JM; Traylor, A | 1 |
Kasukabe, T; Kumakura, S; Yamaguchi, Y | 1 |
Bogo, MR; Carvalho-Silva, M; de Moura, AB; Deroza, PFP; Ferreira, GC; Gomes, LM; Gomes, ML; Kist, LW; Malgarin, F; Quevedo, J; Réus, GZ; Rico, EP; Scaini, G; Schuck, PF; Streck, EL; Zugno, AI | 1 |
He, M; Ichinose, T; Nishikawa, M; Shibamoto, T; Sun, G; Yoshida, S | 1 |
Amiot, BP; Chen, HS; Joo, DJ; Li, Y; Nyberg, SL; Rinaldo, P; Shaheen, M | 1 |
Constantino, L; Dal-Pizzol, F; Damásio, D; Fraga, C; Gonçalves, RC; Michels, M; Ritter, C | 1 |
Araújo Montoya, BO; Brum, PO; Campos Soares, M; Carazza Kessler, FG; Castro-Faria-Neto, HC; Dal-Pizzol, F; Fonseca Moreira, JC; Gasparotto, J; Gelain, DP; Góes Valente, WC; Ong, LK; Panzenhagen, AC; Peixoto, DO; Reis, PA; Schirato, GV; Senger, MR; Silva, FP; Telles de Sá Moreira, E | 1 |
Aguayo, R; Gajardo, A; Lillo-Moya, J; Panieri, E; Prieto, JC; Puentes, Á; Ramos, C; Rodrigo, R; Rojas-Solé, C; Saso, L | 1 |
Dong, Y; Du, GF; Fan, X; Le, YJ; Yang, XY; Yin, A | 1 |
Bao, Y; Chang, X; Dong, S; Duan, X; Li, Y; Lin, J; Shan, H; Tan, Y; Zhang, H | 1 |
5 review(s) available for acetylcysteine and deferoxamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antidotes: benefits and risks.
Topics: Acetylcysteine; Animals; Antidotes; Deferoxamine; Flumazenil; Humans; Naloxone | 1995 |
Clinical applications of commonly used contemporary antidotes. A US perspective.
Topics: Acetylcysteine; Antidotes; Antivenins; Atropine; Deferoxamine; Flumazenil; Humans; Hydroxocobalamin; Naloxone; Physostigmine; Poisoning; Succimer | 1997 |
The role of antioxidants treatment on the pathogenesis of malarial infections: a review.
Topics: Acetylcysteine; Antimalarials; Antioxidants; Ascorbic Acid; Deferoxamine; Folic Acid; Humans; Malaria; Oxidative Stress; Plasmodium; Vitamin E | 2014 |
Joint Cardioprotective Effect of Vitamin C and Other Antioxidants against Reperfusion Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Biomarkers; Deferoxamine; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Male; Myocardial Infarction; Oxidative Stress; Percutaneous Coronary Intervention; Polyphenols; Protective Agents; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; Stroke Volume; Tocopherols; Ventricular Function, Left | 2021 |
2 trial(s) available for acetylcysteine and deferoxamine
Article | Year |
---|---|
The effects of N-acetylcysteine and deferoxamine on plasma cytokine and oxidative damage parameters in critically ill patients with prolonged hypotension: a randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Antioxidants; Critical Illness; Deferoxamine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypotension; Interleukin-6; Male; Middle Aged; Nitrites; Oxidative Stress; Siderophores | 2012 |
N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Aged; Critical Illness; Deferoxamine; Double-Blind Method; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Hypotension; Incidence; Intensive Care Units; Male; Middle Aged | 2016 |
113 other study(ies) available for acetylcysteine and deferoxamine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a Water-Soluble Indolylmaleimide Derivative IM-93 Showing Dual Inhibition of Ferroptosis and NETosis.
Topics: | 2019 |
Novel pentacyclic triterpenes exhibiting strong neuroprotective activity in SH-SY5Y cells in salsolinol- and glutamate-induced neurodegeneration models.
Topics: Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glutamic Acid; Humans; Isoquinolines; Membrane Potential, Mitochondrial; Models, Biological; Molecular Structure; Neuroprotective Agents; Oxidative Stress; Structure-Activity Relationship; Triazoles; Triterpenes | 2021 |
The formation of free radicals by cardiac myocytes under oxidative stress and the effects of electron-donating drugs.
Topics: Acetylcysteine; Animals; Deferoxamine; Electron Spin Resonance Spectroscopy; Free Radicals; In Vitro Techniques; Lipid Peroxides; Metmyoglobin; Myocardium; Oxidation-Reduction; Peroxides; Rabbits; Reperfusion Injury; Tiopronin | 1991 |
Calcium-dependent and calcium-independent mechanisms of irreversible cell injury in cultured hepatocytes.
Topics: Acetylcysteine; Animals; Calcium; Cell Survival; Cells, Cultured; Deferoxamine; Dithiothreitol; Glucose Oxidase; Glutathione; Homeostasis; Hydrogen Peroxide; Iron; Liver; Male; NADP; Onium Compounds; Phosphorylase a; Rats; Rats, Inbred Strains; Trityl Compounds; Vitamin K | 1986 |
Modification of cisplatin-induced renal p-aminohippurate uptake alteration and lipid peroxidation by thiols, Ginkgo biloba extract, deferoxamine and torbafylline.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Cisplatin; Deferoxamine; Glutathione; In Vitro Techniques; Kidney Cortex; Lipid Peroxidation; Male; p-Aminohippuric Acid; Pentoxifylline; Plant Extracts; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds | 1995 |
Comparison of N-methyl hexanoylhydroxamic acid, a novel antioxidant, with desferrioxamine and N-acetyl cysteine against reperfusion-induced dysfunctions in isolated rat heart.
Topics: Acetylcysteine; Animals; Antioxidants; Cardiovascular Agents; Deferoxamine; Heart; Heart Rate; Hydroxamic Acids; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Perfusion; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Pressure | 1993 |
The role of reactive oxygen intermediates in osteoclastic bone resorption.
Topics: Acetylcysteine; Animals; Animals, Newborn; Antioxidants; Bone Resorption; Cell Survival; Cells, Cultured; Deferoxamine; Free Radical Scavengers; NF-kappa B; Osteoclasts; Pyrrolidines; Rats; Reactive Oxygen Species; Thiocarbamates | 1995 |
The consequences of nitrofurantoin-induced oxidative stress in isolated rat hepatocytes: evaluation of pathobiochemical alterations.
Topics: Acetylcysteine; Animals; Carmustine; Deferoxamine; Dithiothreitol; Glutathione; Glutathione Reductase; L-Lactate Dehydrogenase; Liver; Male; Malondialdehyde; Nitrofurantoin; Oxidation-Reduction; Rats; Rats, Wistar; Stress, Physiological | 1994 |
Fibre-induced lipid peroxidation leads to DNA adduct formation in Salmonella typhimurium TA104 and rat lung fibroblasts.
Topics: Acetylcysteine; Animals; Antidotes; Asbestos, Crocidolite; Asbestos, Serpentine; Buthionine Sulfoximine; Carcinogens; Deferoxamine; DNA; DNA Adducts; Enzyme Inhibitors; Ferrozine; Fibroblasts; Glass; Glutathione; Lipid Peroxidation; Lung; Malondialdehyde; Methionine Sulfoximine; Mineral Fibers; Rats; Salmonella typhimurium; Thiobarbituric Acid Reactive Substances | 1996 |
Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells.
Topics: Acetylcysteine; Animals; Apoptosis; Apoptosis Regulatory Proteins; Aurintricarboxylic Acid; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Caspase 1; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cysteine Endopeptidases; Dactinomycin; Deferoxamine; Enzyme Activation; Humans; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Nerve Growth Factors; PC12 Cells; Rats; RNA; Serpins; Viral Proteins | 1996 |
Serum deprivation inhibits glutathione depletion-induced death in embryonic cortical neurons: evidence against oxidative stress as a final common mediator of neuronal apoptosis.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Brain-Derived Neurotrophic Factor; Butylated Hydroxyanisole; Cells, Cultured; Cerebral Cortex; Culture Media, Serum-Free; Cystine; Deferoxamine; Glutathione; Insulin; Neurons; Oxidative Stress; Rats; Rats, Sprague-Dawley | 1996 |
Studies into the mechanism of NF kappa B activation by IL1, TNF and H2O2 in primary and transformed endothelial cells.
Topics: Acetylcysteine; Allopurinol; Cell Line, Transformed; Cells, Cultured; Cyclic N-Oxides; Deferoxamine; DNA-Binding Proteins; Endothelium, Vascular; Humans; Hydrogen Peroxide; I-kappa B Proteins; Interleukin-1; Kinetics; NF-kappa B; NF-KappaB Inhibitor alpha; Pyrrolidines; Thiocarbamates; Tumor Necrosis Factor-alpha; Umbilical Veins | 1997 |
Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells.
Topics: Acetylcysteine; Actins; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antioxidants; Apoptosis; Bleomycin; Carcinoma, Hepatocellular; Deferoxamine; Fas Ligand Protein; fas Receptor; Glutathione; Humans; Hydrogen Peroxide; Ligands; Membrane Glycoproteins; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 1997 |
Active oxygen-mediated chromosomal 1-2 Mbp giant DNA fragmentation into internucleosomal DNA fragmentation in apoptosis of glioma cells induced by glutamate.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Ascorbic Acid; Catalase; Chromosomes; Deferoxamine; DNA Fragmentation; Free Radical Scavengers; Glioma; Glutamic Acid; Glutathione; Hydrogen Peroxide; Iron Chelating Agents; Oxidation-Reduction; Oxygen; Phenanthrolines; Rats; Tumor Cells, Cultured | 1998 |
Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies.
Topics: Acetylcysteine; Alprostadil; Antioxidants; Chelating Agents; Deferoxamine; Hemochromatosis; Humans; Infant, Newborn; Liver Transplantation; Retrospective Studies; Selenium; Treatment Outcome; Vitamin E | 1998 |
Role of H2O2 and heme-containing O2 sensors in hypoxic regulation of tyrosine hydroxylase gene expression.
Topics: Acetylcysteine; Actins; Amitrole; Animals; Antioxidants; Biosensing Techniques; Catalase; Cell Hypoxia; Deferoxamine; Gene Expression Regulation, Enzymologic; Heme; Hydrogen Peroxide; Kinetics; Oxygen; PC12 Cells; Rats; RNA, Messenger; Tiopronin; Transcription, Genetic; Tyrosine 3-Monooxygenase | 1998 |
Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression.
Topics: Acetylcysteine; Amitrole; Antioxidants; Catalase; Chelating Agents; Deferoxamine; Endothelium, Vascular; Fluoresceins; Free Radical Scavengers; Gene Expression Regulation; Genes, fos; Hemodynamics; Humans; Hydrogen Peroxide; Reactive Oxygen Species; RNA; Thiourea; Umbilical Cord | 1998 |
Acute paraquat poisoning: increased toxicity in one case with high alcohol intake.
Topics: Acetylcysteine; Alcohol Drinking; Antidotes; Deferoxamine; Diuretics, Osmotic; Ethanol; Excipients; Expectorants; Fatal Outcome; Herbicides; Humans; Male; Mannitol; Middle Aged; Paraquat; Polyethylene Glycols | 1998 |
Bax and Bak proteins require caspase activity to trigger apoptosis in sympathetic neurons.
Topics: Acetylcysteine; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Deferoxamine; Membrane Proteins; Nerve Tissue Proteins; Neurons; Phosphodiesterase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Superior Cervical Ganglion | 1998 |
Air pollution particles induce IL-6 gene expression in human airway epithelial cells via NF-kappaB activation.
Topics: Acetylcysteine; Air Pollutants; Bronchi; Carbon; Cell Line; Coal Ash; Deferoxamine; DNA; Epithelial Cells; Free Radical Scavengers; Fuel Oils; Gene Expression Regulation; Humans; Interleukin-6; Metals; NF-kappa B; Particulate Matter; Promoter Regions, Genetic; RNA, Messenger; Transfection | 1998 |
Analysis of air pollution particulate-mediated oxidant stress in alveolar macrophages.
Topics: Acetylcysteine; Air Pollutants; Animals; Cell Line; Chelating Agents; Chemokines, CC; Cricetinae; Cytokines; Deferoxamine; Environmental Exposure; Fluoresceins; Free Radical Scavengers; Macrophage Inflammatory Proteins; Macrophages, Alveolar; Oxidative Stress; Particle Size; Reactive Oxygen Species; RNA; Tumor Necrosis Factor-alpha | 1998 |
DNA damage induces p21 protein expression by inhibiting ubiquitination in ML-1 cells.
Topics: Acetylcysteine; Cell Nucleus; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Cytarabine; Deferoxamine; DNA Damage; Etoposide; Gene Expression Regulation; Hydroxyurea; Polyribosomes; RNA, Messenger; Tumor Cells, Cultured; Ubiquitins | 1998 |
Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice.
Topics: Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Animals; Chelating Agents; Deferoxamine; Dose-Response Relationship, Drug; Kupffer Cells; Liver; Male; Mice | 1999 |
Direct proteasome inhibition by clasto-lactacystin beta-lactone permits the detection of ubiquitinated p21(waf1) in ML-1 cells.
Topics: Acetylcysteine; Antibodies; Blotting, Western; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Endopeptidases; Deferoxamine; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Humans; Lactones; Multienzyme Complexes; Proteasome Endopeptidase Complex; Tumor Cells, Cultured; Ubiquitins | 1999 |
Safrole-induced oxidative damage in the liver of Sprague-Dawley rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Alanine Transaminase; Animals; Antidotes; Antioxidants; Aspartate Aminotransferases; Carcinogens; Deferoxamine; Deoxyguanosine; DNA Adducts; DNA Damage; Lipid Peroxides; Liver; Male; Microsomes, Liver; Oxidative Stress; Rats; Rats, Sprague-Dawley; Safrole; Vitamin E | 1999 |
Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease.
Topics: Acetylcysteine; alpha-Synuclein; Antioxidants; Brain; Cytochrome c Group; Deferoxamine; Humans; Hydrogen Peroxide; Immunohistochemistry; Lewy Body Disease; Nerve Tissue Proteins; Oxidative Stress; Recombinant Proteins; Synucleins | 1999 |
Inhibition of NFkappaB activation with antioxidants is correlated with reduced cytokine transcription in PTC.
Topics: Acetylcysteine; Animals; Antioxidants; Catalase; Cell Survival; Cytokines; Deferoxamine; Hydrogen Peroxide; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Lipopolysaccharides; Male; NF-kappa B; Pyrrolidines; Quercetin; Rats; Rats, Wistar; Thiocarbamates; Transcription, Genetic | 1999 |
Ischemia-reperfusion injury of rabbit kidney: comparative effects of desferrioxamine and N-acetylcysteine as antioxidants.
Topics: Acetylcysteine; Animals; Antioxidants; Aspartate Aminotransferases; Deferoxamine; Glutathione; Ischemia; Kidney; Kidney Cortex; L-Lactate Dehydrogenase; Microcirculation; Necrosis; Rabbits; Renal Circulation; Reperfusion Injury; Vitamin E | 2000 |
Effect of N-acetylcysteine and deferoxamine on endogenous antioxidant defense system gene expression in a rat hepatocyte model of cocaine cytotoxicity.
Topics: Acetylcysteine; Animals; Antioxidants; Catalase; Cells, Cultured; Cocaine; Deferoxamine; Diploidy; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; Hydrogen Peroxide; Liver; Male; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Superoxide Dismutase | 2000 |
Effects of clinically used antioxidants in experimental pneumococcal meningitis.
Topics: Acetylcysteine; Animals; Antioxidants; Deferoxamine; Disease Models, Animal; Meningitis, Pneumococcal; Neurons; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2000 |
Effect of cigarette smoke on salivary proteins and enzyme activities.
Topics: Acetylcysteine; Acid Phosphatase; Amylases; Antioxidants; Ascorbic Acid; Blood Proteins; Deferoxamine; Female; Glutathione; Humans; L-Lactate Dehydrogenase; Male; Nicotiana; Plants, Toxic; Saliva; Salivary Proteins and Peptides; Smoke; Smoking; Time Factors | 2000 |
Glutathione oxidation and PTPase inhibition by hydrogen peroxide in Caco-2 cell monolayer.
Topics: Acetylcysteine; Antineoplastic Agents, Alkylating; Caco-2 Cells; Carmustine; Catalase; Cell Membrane Permeability; Chelating Agents; Deferoxamine; Free Radical Scavengers; Glutathione; Humans; Hydrogen Peroxide; Intestinal Mucosa; Intestines; Iron; Maleates; Oxidants; Oxidation-Reduction; Phenanthrolines; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Signal Transduction; Sulfhydryl Compounds; Superoxide Dismutase; Thiomalates; Tight Junctions; Vitamin A; Vitamin E | 2000 |
Regulation of endothelial heme oxygenase activity during hypoxia is dependent on chelatable iron.
Topics: Acetylcysteine; Aminolevulinic Acid; Animals; Aorta, Thoracic; Carbon Monoxide; Cattle; Cell Hypoxia; Cells, Cultured; Deferoxamine; Endothelium, Vascular; Enzyme Activation; Ferric Compounds; Free Radical Scavengers; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hypoxia; Iron Chelating Agents; Male; Oxidative Stress; Phenanthrolines; Photosensitizing Agents; Quaternary Ammonium Compounds | 2000 |
Mitochondrial involvement in cocaine-treated rat hepatocytes: effect of N-acetylcysteine and deferoxamine.
Topics: Acetylcysteine; Animals; Apoptosis; Caspase 3; Caspases; Chelating Agents; Cocaine; Cytochrome c Group; Deferoxamine; DNA Fragmentation; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Free Radical Scavengers; Heat-Shock Proteins; Hepatocytes; HSP20 Heat-Shock Proteins; Male; Membrane Potentials; Mitochondria, Liver; Muscle Proteins; Rats; Rats, Wistar | 2001 |
Kupffer cells and neutrophils as paracrine regulators of the heme oxygenase-1 gene in hepatocytes after hemorrhagic shock.
Topics: Acetylcysteine; Animals; Antioxidants; Blood Pressure; Cells, Cultured; Chromans; Clodronic Acid; Deferoxamine; Disease Models, Animal; Gadolinium; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hepatocytes; Kupffer Cells; Male; Neutrophils; Rats; Rats, Sprague-Dawley; Resuscitation; Shock, Hemorrhagic; Time Factors; Vinblastine | 2001 |
A study on the role of nitric oxide and iron in 3-morpholino-sydnonimine-induced increases in dopamine release in the striatum of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Ascorbic Acid; Corpus Striatum; Deferoxamine; Dialysis Solutions; Dopamine; Dose-Response Relationship, Drug; Free Radical Scavengers; Homovanillic Acid; Iron; Male; Metalloporphyrins; Molsidomine; Movement; Nitric Oxide; Nitric Oxide Donors; Rats; Rats, Wistar; Uric Acid | 2001 |
Hydrogen peroxide mediates activation of nuclear factor of activated T cells (NFAT) by nickel subsulfide.
Topics: Acetylcysteine; Animals; Calcineurin; Calcium; Carcinogens; Cells, Cultured; Chelating Agents; Cyclosporine; Deferoxamine; DNA-Binding Proteins; Drug Synergism; Fibroblasts; Free Radical Scavengers; Hydrogen Peroxide; Mice; NFATC Transcription Factors; Nickel; Nuclear Proteins; Reactive Oxygen Species; Thapsigargin; Transcription Factors; Transcriptional Activation; Transfection | 2001 |
Antioxidants inhibit mercuric chloride-induced early vasculitis.
Topics: Acetylcysteine; Animals; Antioxidants; Cell Line; Chymases; Deferoxamine; Immunoenzyme Techniques; Immunoglobulin E; Interleukin-4; Male; Mast Cells; Mercuric Chloride; Pyruvic Acid; Rats; Rats, Inbred BN; Serine Endopeptidases; Vasculitis | 2002 |
Reactive oxygen species generated during myocardial ischemia enable energetic recovery during reperfusion.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcysteine; Adenosine Triphosphate; Animals; Antioxidants; Deferoxamine; Energy Metabolism; Free Radical Scavengers; In Vitro Techniques; Iron Chelating Agents; Ischemic Preconditioning, Myocardial; Male; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Oxidative Stress; Perfusion; Phosphocreatine; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2002 |
Numerous proteins in Mammalian cells are prone to iron-dependent oxidation and proteasomal degradation.
Topics: Acetylcysteine; Blotting, Western; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Deferoxamine; Ferric Compounds; Humans; Iron; Iron Chelating Agents; Multienzyme Complexes; Oxidation-Reduction; Proteasome Endopeptidase Complex; Proteins; Quaternary Ammonium Compounds; Tumor Cells, Cultured | 2002 |
In vitro activation of dibromoacetonitrile to cyanide: role of xanthine oxidase.
Topics: Acetonitriles; Acetylcysteine; Catalase; Cyanides; Deferoxamine; Disinfection; Dithiothreitol; Dose-Response Relationship, Drug; Free Radical Scavengers; Glutathione; Hypoxanthine; In Vitro Techniques; Oxidation-Reduction; Superoxide Dismutase; Water Pollutants, Chemical; Xanthine Oxidase | 2003 |
A phosphomimetic mutation at Ser-138 renders iron regulatory protein 1 sensitive to iron-dependent degradation.
Topics: Acetylcysteine; Amino Acid Sequence; Animals; Cell Line; Cysteine Proteinase Inhibitors; Deferoxamine; Humans; Iron; Iron Chelating Agents; Iron Regulatory Protein 1; Leupeptins; Mice; Molecular Sequence Data; Mutation; Point Mutation; Recombinant Proteins; Sequence Homology, Amino Acid; Serine | 2003 |
Amyloid precursor protein carboxy-terminal fragments modulate G-proteins and adenylate cyclase activity in Alzheimer's disease brain.
Topics: Acetylcysteine; Adenylyl Cyclases; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Protein Precursor; Binding Sites; Case-Control Studies; Cell Membrane; Deferoxamine; Dose-Response Relationship, Drug; Female; Free Radical Scavengers; Frontal Lobe; Glutathione; GTP Phosphohydrolases; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Hippocampus; Humans; Hydrogen Peroxide; Iron Chelating Agents; Oxidants; Peptide Fragments; Sulfur Isotopes | 2003 |
Effect of hypoxia on the expression of fractalkine in human endothelial cells.
Topics: Acetylcysteine; Cell Hypoxia; Cells, Cultured; Chemokine CX3CL1; Chemokines, CX3C; Deferoxamine; Endothelial Cells; Endothelium, Vascular; Humans; Interferon-gamma; Iron Chelating Agents; Membrane Proteins; Oxygen; RNA, Messenger; Vascular Endothelial Growth Factor A | 2003 |
Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis.
Topics: Acetylcysteine; Animals; Deferoxamine; Drug Therapy, Combination; Free Radical Scavengers; Iron Chelating Agents; Male; Oxidative Stress; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Survival Rate | 2004 |
Therapeutic benefits of antioxidants during sepsis: is protection against oxidant-mediated tissue damage only half the story?
Topics: Acetylcysteine; Animals; Antioxidants; Deferoxamine; Free Radical Scavengers; Humans; Iron Chelating Agents; Oxidative Stress; Sepsis | 2004 |
Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor.
Topics: Acetylcysteine; Asbestos, Crocidolite; Asbestos, Serpentine; Chelating Agents; Deferoxamine; Epithelial Cells; Free Radical Scavengers; Humans; Kinetochores; Lysine; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagenesis; Phytic Acid; Superoxide Dismutase; Thiourea | 2004 |
Characterization and modulation of the transferrin receptor on brain capillary endothelial cells.
Topics: Acetylcysteine; Animals; Astrocytes; Capillaries; Cattle; Cells, Cultured; Cerebrovascular Circulation; Deferoxamine; Down-Regulation; Endocytosis; Endothelial Cells; Extracellular Space; Free Radical Scavengers; Inflammation; Iron; Lipopolysaccharides; Receptors, Transferrin; Transferrin; Tyrphostins | 2004 |
Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats.
Topics: Acetylcysteine; Animals; Antioxidants; Carbon Tetrachloride; Deferoxamine; Hydrocarbons; Inflammation; Liver; Liver Failure, Acute; Male; Models, Animal; Necrosis; Oxidative Stress; Rats; Rats, Wistar | 2004 |
Oligomycin inhibits HIF-1alpha expression in hypoxic tumor cells.
Topics: Acetylcysteine; Amino Acids, Dicarboxylic; Cell Hypoxia; Chromans; Deferoxamine; DNA-Binding Proteins; Electron Transport; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mitochondria; Nuclear Proteins; Oligomycins; Proton-Translocating ATPases; Reactive Oxygen Species; Transcription Factors; Tumor Cells, Cultured | 2005 |
Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration.
Topics: Acetylcysteine; Animals; Deferoxamine; Iron Chelating Agents; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Parkinsonian Disorders; Proteasome Inhibitors; Substantia Nigra; Treatment Outcome; Ubiquitin | 2005 |
Apoptosis, necrosis and hypoxia inducible factor-1 in human head and neck squamous cell carcinoma cultures.
Topics: Acetylcysteine; Apoptosis; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Nucleus; Cell Shape; Cobalt; Deferoxamine; DNA-Binding Proteins; Flow Cytometry; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Necrosis; Nuclear Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcription Factors | 2005 |
Nickel compound-induced DNA single-strand breaks in chromosomal and nuclear chromatin in human blood lymphocytes in vitro: role of oxidative stress and intracellular calcium.
Topics: Acetylcysteine; Analysis of Variance; Calcium; Catalase; Chromatin; Cytogenetic Analysis; Dantrolene; Deferoxamine; DNA Damage; Egtazic Acid; Humans; In Situ Nick-End Labeling; Lymphocytes; Microscopy, Electron; Mutagenicity Tests; Nickel; Oxidative Stress; Superoxide Dismutase; Thiourea; Verapamil | 2005 |
Role of oxidative stress, mitochondrial membrane potential, and calcium homeostasis in nickel sulfate-induced human lymphocyte death in vitro.
Topics: Acetylcysteine; Calcium; Catalase; Cell Death; Cyclosporine; Deferoxamine; Glutathione; Homeostasis; Humans; Hydrogen Peroxide; Lymphocytes; Mannitol; Membrane Potentials; Mitochondria; Nickel; Oxidative Stress; Thiourea | 2005 |
N-acetylcysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure.
Topics: Acetylcysteine; Animals; Coal; Deferoxamine; Dust; Free Radicals; Inflammation; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Wistar; Siderophores; Trachea | 2005 |
Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat.
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Deferoxamine; Disease Models, Animal; Interleukin-1; Lipopolysaccharides; Male; Oxidative Stress; Rats; Rats, Wistar; Respiratory Distress Syndrome; Siderophores; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2006 |
More antioxidants in sepsis: still paved with uncertainties.
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Deferoxamine; Disease Models, Animal; Humans; Oxidation-Reduction; Oxidative Stress; Respiratory Distress Syndrome; Sepsis; Siderophores | 2006 |
Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway.
Topics: Acetylcysteine; Activating Transcription Factor 3; Amino Acids, Dicarboxylic; Basic Helix-Loop-Helix Transcription Factors; Breast Neoplasms; Cells, Cultured; Cyanides; Deferoxamine; Enzyme Activation; Free Radical Scavengers; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma; Mixed Function Oxygenases; Neurons; Oxygen; Proto-Oncogene Proteins c-jun; Siderophores; Signal Transduction; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Von Hippel-Lindau Tumor Suppressor Protein | 2007 |
Successful pregnancy outcome following maternal intravenous immunoglobulin treatment in a woman with recurrent perinatal haemochromatosis.
Topics: Acetylcysteine; Adult; Deferoxamine; Diagnosis, Differential; Female; Ferritins; Fetal Diseases; Free Radical Scavengers; Gestational Age; Hemochromatosis; Humans; Hydrops Fetalis; Infant, Newborn; Live Birth; Liver Failure, Acute; Pregnancy; Recurrence; Treatment Outcome; Vitamin E; Vitamin K | 2006 |
Huntingtin inclusion bodies are iron-dependent centers of oxidative events.
Topics: Acetylcysteine; Animals; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Deferoxamine; Exons; Heat-Shock Proteins; Huntington Disease; Inclusion Bodies; Iron; Microscopy, Confocal; Oxidation-Reduction; Phenanthridines; Rats; Recombinant Fusion Proteins | 2006 |
Histidine-induced injury to cultured liver cells, effects of histidine derivatives and of iron chelators.
Topics: Acetylcysteine; Animals; Butylated Hydroxytoluene; Cell Survival; Cells, Cultured; Chromans; Deferoxamine; Hepatocytes; Histidine; Iron Chelating Agents; Lipid Peroxidation; Male; Molecular Structure; Organ Preservation Solutions; Rats; Rats, Wistar | 2007 |
[Prooxidant and cytotoxic action of N-acetylcysteine and glutathione combined with vitamin Bl2b].
Topics: Acetylcysteine; Antioxidants; Apoptosis; Catalase; Cell Line, Tumor; Cell Physiological Phenomena; Deferoxamine; Drug Synergism; Free Radical Scavengers; Glutathione; Humans; Iron Compounds; Oxidation-Reduction; Oxidative Stress; Phenanthrolines; Pyruvic Acid; Siderophores; Vitamin B 12 | 2007 |
Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Colitis, Ulcerative; Colon; Deferoxamine; Dextran Sulfate; Disease Models, Animal; Electron Transport Complex II; Electron Transport Complex IV; Gastrointestinal Agents; Leukocyte Count; Lipid Peroxidation; Male; Mitochondria; Oxidative Stress; Rats; Rats, Wistar; Succinate Dehydrogenase; Thiobarbituric Acid Reactive Substances | 2007 |
Mitochondrial superoxide production is related to the control of cytokine release from peritoneal macrophage after antioxidant treatment in septic rats.
Topics: Acetylcysteine; Animals; Antioxidants; Cytokines; Deferoxamine; Macrophages, Peritoneal; Male; Mitochondria; Rats; Rats, Wistar; Sepsis; Signal Transduction; Superoxides; Thiobarbituric Acid Reactive Substances | 2007 |
Wear particles generated from studded tires and pavement induces inflammatory reactions in mouse macrophage cells.
Topics: Acetylcysteine; Androstadienes; Animals; Cell Line; Cell Survival; Cytokines; Deferoxamine; Free Radical Scavengers; Gene Expression; Inflammation; Interleukin-6; Lipid Peroxidation; Macrophages; Mice; Microscopy, Electron, Scanning; Motor Vehicles; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Particulate Matter; Quartz; Reactive Oxygen Species; RNA, Messenger; Silicon Dioxide; Tumor Necrosis Factor-alpha; Wortmannin | 2007 |
Antioxidant treatment prevented late memory impairment in an animal model of sepsis.
Topics: Acetylcysteine; Animals; Antioxidants; Avoidance Learning; Cecum; Deferoxamine; Disease Models, Animal; Habituation, Psychophysiologic; Intestinal Perforation; Ligation; Male; Memory Disorders; Rats; Rats, Wistar; Sepsis | 2007 |
Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Bleomycin; Catalase; Deferoxamine; Drug Therapy, Combination; Fibrosis; Iron Chelating Agents; L-Lactate Dehydrogenase; Lipid Peroxidation; Lung; Lung Diseases; Male; Mice; Mice, Inbred Strains; Oxidative Stress; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2008 |
The effect of n-acetylcysteine and deferoxamine on exercise-induced oxidative damage in striatum and hippocampus of mice.
Topics: Acetylcysteine; Animals; Catalase; Corpus Striatum; Deferoxamine; Hippocampus; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Physical Conditioning, Animal; Superoxide Dismutase | 2008 |
Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Antioxidants; Blood Platelets; Chelating Agents; Deferiprone; Deferoxamine; Erythrocytes; Female; Humans; Male; Myelodysplastic Syndromes; Neutrophils; Oxidative Stress; Pyridones | 2007 |
Inhibitory effect of 6-formylpterin on HIF-1alpha protein accumulation.
Topics: Acetylcysteine; Antioxidants; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Deferoxamine; Dose-Response Relationship, Drug; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Pterins; Reactive Oxygen Species; RNA, Messenger | 2007 |
Inhibition of brain creatine kinase activity after renal ischemia is attenuated by N-acetylcysteine and deferoxamine administration.
Topics: Acetylcysteine; Animals; Antioxidants; Brain; Brain Diseases, Metabolic; Creatine Kinase; Deferoxamine; Down-Regulation; Ischemia; Kidney Diseases; Male; Nerve Degeneration; Oxidative Stress; Rats; Rats, Wistar; Subcellular Fractions; Time Factors; Treatment Outcome; Uremia | 2008 |
Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania.
Topics: Acetylcysteine; Animals; Bipolar Disorder; Central Nervous System Stimulants; Deferoxamine; Dextroamphetamine; Free Radical Scavengers; Hyperkinesis; Male; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar | 2008 |
TNF-alpha stimulates Akt by a distinct aPKC-dependent pathway in premalignant keratinocytes.
Topics: Acetylcysteine; Androstadienes; Apoptosis; Blotting, Western; Caspases; Cell Line; Cell Survival; Chromones; Deferoxamine; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Humans; Keratinocytes; Leupeptins; Morpholines; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Tocopherols; Tumor Necrosis Factor-alpha; Wortmannin | 2008 |
Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Deferoxamine; Drug Therapy, Combination; Free Radical Scavengers; Gentamicins; Male; Rats; Rats, Wistar; Siderophores | 2009 |
Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity.
Topics: Acetylcysteine; Animals; Catalase; Copper; Deferoxamine; Doxorubicin; Glutathione Peroxidase; Iron; Lipid Peroxidation; Liver; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley; Selenium; Superoxide Dismutase; Zinc | 2009 |
Antioxidant treatment reverses organ failure in rat model of sepsis: role of antioxidant enzymes imbalance, neutrophil infiltration, and oxidative stress.
Topics: Acetylcysteine; Animals; Antioxidants; Catalase; Deferoxamine; Disease Models, Animal; Kidney; Lung; Male; Multiple Organ Failure; Neutrophil Infiltration; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Sepsis; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Urea | 2011 |
Effects of N-acetylcysteine/deferoxamine, taurine and RC-3095 on respiratory chain complexes and creatine kinase activities in rat brain after sepsis.
Topics: Acetylcysteine; Animals; Bombesin; Brain; Creatine Kinase; Deferoxamine; Electron Transport; Male; Peptide Fragments; Rats; Rats, Wistar; Sepsis; Taurine | 2010 |
Inhibition of mitochondrial respiratory chain in the brain of rats after renal ischemia is prevented by N-acetylcysteine and deferoxamine.
Topics: Acetylcysteine; Animals; Cell Respiration; Deferoxamine; Disease Models, Animal; Drug Combinations; Drug Synergism; Electron Transport; Electron Transport Complex I; Free Radical Scavengers; Ischemia; Kidney Diseases; Male; Rats; Rats, Wistar | 2010 |
Inhibition of mitochondrial respiratory chain in the brain of rats after hepatic failure induced by acetaminophen.
Topics: Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Animals; Antioxidants; Brain; Deferoxamine; Down-Regulation; Drug Evaluation, Preclinical; Electron Transport; Liver Failure; Male; Mitochondria; Rats; Rats, Wistar; Taurine | 2011 |
Therapeutic management of neonatal hemochromatosis: report of four cases and literature review.
Topics: Acetylcysteine; Antioxidants; Deferoxamine; Female; Hemochromatosis; Humans; Infant, Newborn; Selenium; Siderophores; Vitamin E | 2011 |
Novel cytochrome p450 bioactivation of a terminal phenyl acetylene group: formation of a one-carbon loss benzaldehyde and other oxidative products in the presence of N-acetyl cysteine or glutathione.
Topics: Acetylcysteine; Acetylene; Animals; Antioxidants; Ascorbic Acid; Benzaldehydes; Cattle; Chelating Agents; Cytochrome P-450 Enzyme System; Deferoxamine; Dogs; Glutathione; Humans; Male; Oxidation-Reduction; Rats; Rats, Sprague-Dawley | 2011 |
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds.
Topics: Acetylcysteine; alpha-Synuclein; Antioxidants; Apigenin; Ascorbic Acid; Deferoxamine; Dose-Response Relationship, Drug; Flavanones; Flavonoids; Humans; Iron Chelating Agents; Microscopy, Confocal; Microscopy, Fluorescence; Molecular Structure; Mutation; Parkinson Disease; Phenols; Polyphenols; Protein Multimerization; Protein Structure, Quaternary; Recombinant Proteins; Spectrometry, Fluorescence; Structure-Activity Relationship | 2011 |
Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease.
Topics: Acetylcysteine; Amino Acids, Branched-Chain; Animals; Antioxidants; Deferoxamine; Disease Models, Animal; Male; Maple Syrup Urine Disease; Memory; Memory Disorders; Rats; Rats, Wistar | 2012 |
Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats.
Topics: Acetylcysteine; Animals; Antioxidants; Avoidance Learning; Behavior, Animal; Cerebral Cortex; Cognition Disorders; Deferoxamine; Free Radical Scavengers; Habituation, Psychophysiologic; Hippocampus; Lipid Peroxidation; Male; Memory; Meningitis, Pneumococcal; Oxidative Stress; Rats; Rats, Wistar; Survivors; Thiobarbituric Acid Reactive Substances | 2012 |
Synergist effects of n-acetylcysteine and deferoxamine treatment on behavioral and oxidative parameters induced by chronic mild stress in rats.
Topics: Acetylcysteine; Animals; Behavior, Animal; Deferoxamine; Drug Synergism; Oxidative Stress; Rats; Stress, Psychological; Thiobarbituric Acid Reactive Substances | 2012 |
Implication of glutathione in the in vitro antiplasmodial mechanism of action of ellagic acid.
Topics: Acetylcysteine; Animals; Antimalarials; Antioxidants; Ascorbic Acid; Buthionine Sulfoximine; Cells, Cultured; Deferoxamine; Drug Synergism; Ellagic Acid; Enzyme Inhibitors; Erythrocytes; Glutathione; Humans; Inhibitory Concentration 50; Mice; Oxidation-Reduction; Plasmodium falciparum; Plasmodium yoelii; Reactive Oxygen Species; Siderophores | 2012 |
Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model.
Topics: Acetylcysteine; Amino Acids, Branched-Chain; Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Deferoxamine; Disease Models, Animal; Hippocampus; Male; Maple Syrup Urine Disease; Memory; Memory Disorders; Oxidative Stress; Protein Precursors; Rats; Rats, Wistar; RNA, Messenger | 2013 |
Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells.
Topics: Acetylcysteine; Animals; Antioxidants; Cells, Cultured; Deferoxamine; Epithelial Cells; Erythropoietin; Gene Expression Regulation; Heme Oxygenase-1; Kidney Tubules, Proximal; MicroRNAs; NF-E2-Related Factor 2; Ochratoxins; Reactive Oxygen Species; Signal Transduction; Swine; Transforming Growth Factor beta | 2013 |
N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Creatinine; Deferoxamine; Erythrocytes; Male; Nephrectomy; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Urine; Warfarin | 2013 |
Deferoxamine promotes osteoblastic differentiation in human periodontal ligament cells via the nuclear factor erythroid 2-related factor-mediated antioxidant signaling pathway.
Topics: Acetylcysteine; Antioxidant Response Elements; Buthionine Sulfoximine; Calcification, Physiologic; Calcium; Cell Differentiation; Cell Line; Deferoxamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Glutamate-Cysteine Ligase; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Humans; Maleates; MAP Kinase Signaling System; NF-E2-Related Factor 2; NF-kappa B; Osteoblasts; Periodontal Ligament; Reactive Oxygen Species; RNA, Small Interfering; Siderophores; Signal Transduction; Vitamin E | 2014 |
Methemoglobin-induced signaling and chemokine responses in human alveolar epithelial cells.
Topics: Acetylcysteine; Alveolar Epithelial Cells; Antioxidants; Cell Line, Tumor; Chemokine CCL2; Chemokines; Deferoxamine; Gene Knockdown Techniques; Humans; I-kappa B Kinase; Interleukin-8; Iron Chelating Agents; MAP Kinase Signaling System; Methemoglobin; NF-kappa B; Oxidative Stress; Phenanthrolines; Phosphorylation; Protein Processing, Post-Translational; Pulmonary Alveoli; RNA Interference | 2014 |
The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity.
Topics: Acetylcysteine; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Cell Survival; Copper; Deferoxamine; Female; Free Radical Scavengers; Humans; Iron; Lysosomes; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasms; Oxidation-Reduction; Phagosomes; Siderophores; Thiosemicarbazones | 2014 |
Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells.
Topics: Acetylcysteine; Aldehydes; Animals; Cells, Cultured; Deferoxamine; Hydrogen Peroxide; Inflammation; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NF-kappa B; Oxidative Stress; Tumor Necrosis Factor-alpha | 2015 |
Organic extracts from African dust storms stimulate oxidative stress and induce inflammatory responses in human lung cells through Nrf2 but not NF-κB.
Topics: Acetylcysteine; Africa; Air Movements; Air Pollutants; Cell Line; Deferoxamine; Dust; Glutathione S-Transferase pi; Heme Oxygenase-1; Humans; Inflammation; Interleukin-6; Interleukin-8; Lung; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Puerto Rico; Reactive Oxygen Species; RNA, Messenger | 2015 |
The effects of n-acetylcysteine and/or deferoxamine on manic-like behavior and brain oxidative damage in mice submitted to the paradoxal sleep deprivation model of mania.
Topics: Acetylcysteine; Aldehydes; Analysis of Variance; Animals; Antimanic Agents; Bipolar Disorder; Brain; Deferoxamine; Disease Models, Animal; Glutathione Peroxidase; Glutathione Reductase; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Sleep Deprivation; Tyrosine | 2015 |
N-acetylcysteine Plus Deferoxamine Improves Cardiac Function in Wistar Rats After Non-reperfused Acute Myocardial Infarction.
Topics: Acetylcysteine; Aldehydes; Animals; Antioxidants; Deferoxamine; Echocardiography; Immunohistochemistry; Iron; Iron Chelating Agents; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Stroke Volume; Sulfhydryl Compounds; Troponin I; Ventricular Function | 2015 |
Antioxidant treatment ameliorates experimental diabetes-induced depressive-like behaviour and reduces oxidative stress in brain and pancreas.
Topics: Acetylcysteine; Animals; Antioxidants; Behavior, Animal; Brain; Deferoxamine; Depressive Disorder; Diabetes Mellitus, Experimental; Free Radical Scavengers; Lipid Peroxidation; Male; Oxidative Stress; Pancreas; Rats; Rats, Wistar; Siderophores | 2016 |
Antioxidant Therapy Alters Brain MAPK-JNK and BDNF Signaling Path-ways in Experimental Diabetes Mellitus.
Topics: Acetylcysteine; Analysis of Variance; Animals; Antioxidants; Brain; Brain-Derived Neurotrophic Factor; Deferoxamine; Diabetes Mellitus, Experimental; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Signal Transduction | 2016 |
The effects of antioxidants on a porcine model of liver hemorrhage.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Crystalloid Solutions; Deferoxamine; Disease Models, Animal; Hepatectomy; Immunohistochemistry; Isotonic Solutions; Liver; Male; Random Allocation; Resuscitation; Shock, Hemorrhagic; Swine | 2016 |
A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload.
Topics: Acetylcysteine; Amyloid beta-Peptides; Animals; Antioxidants; Apoptosis; Benzoates; Brain; Deferasirox; Deferoxamine; Dendrites; Diet; Disease Models, Animal; Drug Therapy, Combination; Iron; Iron Chelating Agents; Iron Overload; Male; Mitochondrial Dynamics; Neurodegenerative Diseases; Phosphorylation; Random Allocation; Rats, Wistar; tau Proteins; Triazoles | 2016 |
Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats.
Topics: Acetylcysteine; Animals; Benzoates; Cardiomyopathies; Cardiotonic Agents; Deferasirox; Deferiprone; Deferoxamine; Drug Combinations; Drug Synergism; Humans; Iron; Iron Chelating Agents; Iron Overload; Iron, Dietary; Male; Malondialdehyde; Mitochondria; Pyridones; Rats; Rats, Wistar; Triazoles; Ventricular Function, Left | 2016 |
N-Acetylcysteine and Desferoxamine Reduce Pulmonary Oxidative Stress Caused by Hemorrhagic Shock in a Porcine Model.
Topics: Acetylcysteine; Animals; Biomarkers; Colloids; Crystalloid Solutions; Deferoxamine; Disease Models, Animal; Drug Evaluation, Preclinical; Fluid Therapy; Free Radical Scavengers; Glutathione Peroxidase; Humans; Infusions, Intravenous; Isotonic Solutions; Lung; Male; Oxidative Stress; Protein Carbonylation; Random Allocation; Rehydration Solutions; Shock, Hemorrhagic; Siderophores; Swine; Thiobarbituric Acid Reactive Substances | 2017 |
Antioxidants reverse the changes in energy metabolism of rat brain after chronic administration of L.-tyrosine.
Topics: Acetylcysteine; Animals; Antioxidants; Brain Chemistry; Citrate (si)-Synthase; Citric Acid Cycle; Creatine Kinase; Deferoxamine; Electron Transport; Energy Metabolism; Male; Oxidative Stress; Rats; Rats, Wistar; Succinate Dehydrogenase; Tyrosine; Tyrosinemias | 2017 |
Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Carbolines; Cell Death; Cell Line; Cyclohexylamines; Deferoxamine; Dose-Response Relationship, Drug; Ferric Compounds; Glutathione; Heme Oxygenase-1; Iron Chelating Agents; Kidney Tubules, Proximal; Membrane Proteins; Mice, Knockout; Phenylenediamines; Piperazines; Quaternary Ammonium Compounds; Signal Transduction; Time Factors | 2018 |
Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis.
Topics: Acetylcysteine; Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Line, Tumor; Cyclohexylamines; Deferoxamine; Dioxolanes; Diterpenes; Drug Synergism; Fibroblasts; Humans; Iron; Mice; Pancreatic Neoplasms; Phenylenediamines; Quinoxalines; Reactive Oxygen Species; Spiro Compounds; Sulfasalazine | 2018 |
Antioxidants Reverse the Changes in the Cholinergic System Caused by L-Tyrosine Administration in Rats.
Topics: Acetylcholinesterase; Acetylcysteine; Animals; Antioxidants; Avoidance Learning; Brain; Choline O-Acetyltransferase; Deferoxamine; Male; Memory; Neuroprotective Agents; Rats, Wistar; Tyrosine | 2018 |
Role of iron and oxidative stress in the exacerbation of allergic inflammation in murine lungs caused by urban particulate matter <2.5 μm and desert dust.
Topics: Acetylcysteine; Animals; Asthma; Cytokines; Deferoxamine; Dust; Iron; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Particulate Matter; Trace Elements | 2019 |
Cold storage of porcine hepatocyte spheroids for spheroid bioartificial liver.
Topics: Acetylcysteine; Albumins; Ammonia; Animals; Cryopreservation; Deferoxamine; Glucose; Hepatocytes; Iron Chelating Agents; Liver, Artificial; Mannitol; Metabolic Clearance Rate; Organ Preservation Solutions; Oxidation-Reduction; Potassium Chloride; Procaine; Spheroids, Cellular; Swine; Transplantation, Heterologous | 2019 |
Stratification to predict the response to antioxidant.
Topics: Acetylcysteine; Adult; Aged; Animals; Antioxidants; Deferoxamine; Humans; Male; Middle Aged; Prognosis; Rats; Rats, Wistar; Retrospective Studies; Sepsis; Treatment Outcome | 2020 |
Neurological impairment caused by Schistosoma mansoni systemic infection exhibits early features of idiopathic neurodegenerative disease.
Topics: Acetylcysteine; Animals; Anthelmintics; Astrocytes; Deferoxamine; Disease Models, Animal; Free Radical Scavengers; Male; Mice; Microglia; Morris Water Maze Test; Neurodegenerative Diseases; Praziquantel; Schistosoma mansoni; Schistosomiasis mansoni; Siderophores | 2021 |
Proteomic Investigation of the Antibacterial Mechanism of Cefiderocol against Escherichia coli.
Topics: Acetylcysteine; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Deferoxamine; Escherichia coli; Flavin-Adenine Dinucleotide; Hydrogen Peroxide; Iron; NAD; NADP; Proteomics; Quinones; Reactive Oxygen Species; Siderophores; Sulfur | 2022 |
RSL3 Inhibits Porcine Epidemic Diarrhea Virus Replication by Activating Ferroptosis.
Topics: Acetylcysteine; Animals; Chlorocebus aethiops; Coronavirus Infections; Deferoxamine; Diarrhea; Ferroptosis; Porcine epidemic diarrhea virus; Swine; Swine Diseases; Vero Cells; Virus Replication | 2023 |